These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19947798)

  • 1. Clopidogrel versus prasugrel: times are changing, but not for everyone.
    Dobesh PP
    Pharmacotherapy; 2009 Dec; 29(12):1393-6. PubMed ID: 19947798
    [No Abstract]   [Full Text] [Related]  

  • 2. Prasugrel: a critical comparison with clopidogrel.
    Reinhart KM; White CM; Baker WL
    Pharmacotherapy; 2009 Dec; 29(12):1441-51. PubMed ID: 19947804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Will prasugrel supersede clopidogrel for acute coronary syndromes?
    Hankey GJ; Eikelboom JW; Langton PE
    Med J Aust; 2008 Apr; 188(7):381-2. PubMed ID: 18393737
    [No Abstract]   [Full Text] [Related]  

  • 4. Switching patients from clopidogrel to prasugrel in acute coronary syndrome: effects of prasugrel loading dose on residual platelet reactivity.
    Lhermusier T; Voisin S; Mejean S; Garcia C; Sié P; Carrié D
    J Thromb Haemost; 2012 Sep; 10(9):1946-9. PubMed ID: 22747669
    [No Abstract]   [Full Text] [Related]  

  • 5. Prasugrel (Effient) vs. clopidogrel (Plavix).
    Med Lett Drugs Ther; 2009 Sep; 51(1320):69-70. PubMed ID: 19738549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prasugrel for acute coronary syndromes: faster, more potent, but higher bleeding risk.
    Lazar LD; Lincoff AM
    Cleve Clin J Med; 2009 Dec; 76(12):707-14. PubMed ID: 19952295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of bleeding in acute coronary syndromes with clopidogrel and prasugrel.
    Rodriguez L; Conde D; Lalor N; Elissamburu P; Trivi M
    Am J Emerg Med; 2013 Aug; 31(8):1287. PubMed ID: 23769852
    [No Abstract]   [Full Text] [Related]  

  • 8. Prasugrel versus clopidogrel antiplatelet therapy after acute coronary syndrome: matching treatments with patients.
    Tcheng JE; Mackay SM
    Am J Cardiovasc Drugs; 2012 Apr; 12(2):83-91. PubMed ID: 22316323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of myocardial infarction after an acute coronary syndrome with clopidogrel and prasugrel.
    Lalor N; Conde D; Rodriguez L; Elissamburu P; Trivi M
    Am J Emerg Med; 2013 Aug; 31(8):1287-8. PubMed ID: 23806726
    [No Abstract]   [Full Text] [Related]  

  • 10. For better or for worse: the future of antiplatelet therapy.
    Alvarez W
    Am J Health Syst Pharm; 2008 Jun; 65(11):1017. PubMed ID: 18499873
    [No Abstract]   [Full Text] [Related]  

  • 11. Ischaemia versus bleeding: the art of clinical decision-making.
    Stone GW
    Lancet; 2009 Feb; 373(9665):695-6. PubMed ID: 19249613
    [No Abstract]   [Full Text] [Related]  

  • 12. [Platelet inhibition with prasugrel].
    Gassanov N; Caglayan E; Nia AM; Erdmann E; Er F
    Dtsch Med Wochenschr; 2010 Aug; 135(31-32):1542-6. PubMed ID: 20665417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prasugrel: a novel antiplatelet agent.
    Riley AB; Tafreshi MJ; Haber SL
    Am J Health Syst Pharm; 2008 Jun; 65(11):1019-28. PubMed ID: 18499874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prasugrel versus Clopidogrel in patients with acute coronary syndromes. Results of the TRITON-TIMI 38 trial].
    Preobrazhenskiĭ DV
    Kardiologiia; 2008; 48(8):72-3. PubMed ID: 18789014
    [No Abstract]   [Full Text] [Related]  

  • 15. Prasugrel versus clopidogrel.
    Serebruany V
    N Engl J Med; 2008 Mar; 358(12):1298; author reply 1299-301. PubMed ID: 18354110
    [No Abstract]   [Full Text] [Related]  

  • 16. Prasugrel versus clopidogrel.
    von Lewinski F; Riggert J; Paulus W
    N Engl J Med; 2008 Mar; 358(12):1299; author reply 1299-301. PubMed ID: 18357639
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of prasugrel in acute coronary syndrome patients.
    Nanau RM; Delzor F; Neuman MG
    Clin Biochem; 2014 May; 47(7-8):516-28. PubMed ID: 24657510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials.
    O'Donoghue ML; Braunwald E; Antman EM; Murphy SA; Bates ER; Rozenman Y; Michelson AD; Hautvast RW; Ver Lee PN; Close SL; Shen L; Mega JL; Sabatine MS; Wiviott SD
    Lancet; 2009 Sep; 374(9694):989-997. PubMed ID: 19726078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Extent of platelet aggregation inhibition and clinical events: new evidence with prasugrel].
    Abbate R; Crea F; De Servi S; Filippi E; Gensini GF; Golinos P; Savonitto S
    G Ital Cardiol (Rome); 2010 Feb; 11(2):127-37. PubMed ID: 20408476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prasugrel for acute and long-term treatment of patients with acute coronary syndromes: what is state-of-the-art?].
    Silber S; Helms TM; Garlichs C; Arntz HR; Weil J; Ince H; Klingenheben T; Hoffmann S; Boudriot E; Steiger H; Zugck C
    Dtsch Med Wochenschr; 2011 Apr; 136(15):782-5. PubMed ID: 21432747
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.